Evidence map›Paper›PMID 38907075›Full record

ArticleScientific reports2024

Author Correction: Novel peptide inhibitor of human tumor necrosis factor-α has antiarthritic activity.

Debasis Sahu, Charu Gupta, Ragothaman M Yennamalli, Shikha Sharma, Saugata Roy, Sadaf Hasan, Pawan Gupta, Vishnu Kumar Sharma, Sujit Kashyap, Santosh Kumar and 5 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Debasis Sahu *Product Development Cell, National Institute of Immunology, New Delhi, India. debasissahu.phd@gmail.com.
Charu Gupta *School of Biomedical Sciences, Galgotias University, Greater Noida, UP, India.
Ragothaman M YennamalliDepartment of Bioinformatics, School of Chemical and Biotechnology, SASTRA Deemed to Be University, Thanjavur, Tamil Nadu, India.
Shikha SharmaAmity Institute of Forensic Sciences, Amity University, Noida, Uttar Pradesh, India.
Saugata RoyCSIR-Institute of Genomics and Integrative Biology, Delhi, India.
Sadaf HasanDepartment of Orthopedics Surgery, New York University School of Medicine, New York, NY, USA.
Pawan GuptaDepartment of Pharmaceutical Chemistry, Shri Vile Parle Kelavani Mandal's Institute of Pharmacy, Dhule, Maharashtra, India.
Vishnu Kumar SharmaDepartment of Pharmacoinformatics, National Institute of Pharmaceutical Education and Research (NIPER), Mohali, Punjab, India.
Sujit KashyapDivision of Pediatric Rheumatology, University of California San Francisco, San Francisco, CA, USA.
Santosh KumarImmunobiology Group, International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, India.
Ved Prakash DwivediImmunobiology Group, International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, India.
Xiangli ZhaoDepartment of Orthopedics Surgery, New York University School of Medicine, New York, NY, USA.
Amulya Kumar PandaProduct Development Cell, National Institute of Immunology, New Delhi, India.
Hasi Rani DasCSIR-Institute of Genomics and Integrative Biology, Delhi, India.
Chuan-Ju LiuDepartment of Orthopedics Surgery, New York University School of Medicine, New York, NY, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38907075
PMCPMC11192870

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.